Immunological tests provide evidence of latent tuberculosis in one third of the global
population, which corresponds to more than two billion individuals. Latent tuberculosis is …

In the absence of symptoms characteristic of tuberculosis (TB), a condition termed clinical
latency, diagnosis is currently impossible by detection of the microorganism itself and resorts …

Tuberculosis is recognized as the world's leading bacterial cause of death. Yet 95% of
infection is believed to exist in an asymptomatic 'latent'form that is defined not by the …

Mycobacterium tuberculosis can persist within the human host for years without causing
disease, in a syndrome known as latent tuberculosis (TB). As one-third of the world …

The post-2015 World Health Organization global tuberculosis strategy recognizes that
elimination requires a focus on reducing the pool of latently infected individuals, an …

Host-and pathogen-specific factors interplay with the environment in a complex fashion to
determine the outcome of infection with Mycobacterium tuberculosis (Mtb), resulting in one …

Tuberculosis (TB) remains a threat to the health of people worldwide. Infection with
Mycobacterium tuberculosis can result in active TB or, more commonly, latent infection …

The aim of this review is to present the current state of knowledge on human latent
tuberculosis infection (LTBI) based on clinical studies and observations, as well as …

The global health community has set itself the task of eliminating tuberculosis (TB) as a
public health problem by 2050. Although progress has been made in global TB control, the …

Tuberculosis is a major cause of death around the world, with most of the 1.5 million deaths
per year attributable to the disease occurring in developing countries. This disease is …